<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-marinedrugs-18-00627">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Han</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>I.W.</given-names>
   </name>
   <name>
    <surname>Cha</surname>
    <given-names>H.J.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>G.Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Fucoidan Induces ROS-Dependent Apoptosis in 5637 Human Bladder Cancer Cells by Downregulating Telomerase Activity via Inactivation of the PI3K/Akt Signaling Pathway</article-title>
  <source>Drug Dev. Res.</source>
  <year>2017</year>
  <volume>78</volume>
  <fpage>37</fpage>
  <lpage>48</lpage>
  <pub-id pub-id-type="doi">10.1002/ddr.21367</pub-id>
  <pub-id pub-id-type="pmid">27654302</pub-id>
 </element-citation>
</ref>
